Table 2.
The difference of bone mineral density and bone turnover marker during study period
| Difference between before and after treatment (mean ± SD) |
p-value | |
|---|---|---|
| Hip BMD (g/cm2) | ||
| group 1 | −0.01 ± 0.03 | 0.147 |
| group 2 | 0.007 ± 0.04 | |
| Femoral neck BMD (g/cm2) | ||
| group 1 | 0.005 ± 0.04 | 0.442 |
| group 2 | −0.014 ± 0.10 | |
| Spine BMD (g/cm2) | ||
| group 1 | 0.043 ± 0.05 | 0.640 |
| group 2 | 0.052 ± 0.06 | |
| Serum osteocalcin (ng/mL) | ||
| group 1 | 0.39 ± 3.25 | 0.764 |
| group 2 | −0.33 ± 1.85 | |
| Serum CTX (ng/mL) | ||
| group 1 | −0.30 ± 0.55 | 0.252 |
| group 2 | −0.09 ± 0.28 | |
BMD bone mineral density; CTX C-terminal telopetide